Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab Top-down vs Step-up in Pediatric Crohn's Disease
NCT01880307Phase 4Terminated
- Sponsor
- Erasmus MC
- Start
- Jan 2013
- Primary completion
- Dec 2014
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 4 trial of infliximab in Crohn's disease, sponsored by Erasmus MC. Started Jan 2013; status: terminated.
02
Drugs
infliximab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01880307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01880307.